High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

Br J Haematol. 2013 Jul;162(2):282-5. doi: 10.1111/bjh.12352. Epub 2013 Apr 18.
No abstract available

Keywords: PReferentially expressed Antigen of the Melanoma Gene; leukaemia antigens; myelodysplastic syndrome; survival; tumour antigens.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / biosynthesis*
  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / metabolism
  • Biomarkers, Tumor / biosynthesis
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Gene Expression Profiling
  • Humans
  • Kaplan-Meier Estimate
  • Myelodysplastic Syndromes / genetics
  • Myelodysplastic Syndromes / metabolism*

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • PRAME protein, human